4//SEC Filing
NEIL GARRY ARTHUR 4
Accession 0001628280-23-018556
CIK 0001534120other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 7:43 AM ET
Size
5.5 KB
Accession
0001628280-23-018556
Insider Transaction Report
Form 4
NEIL GARRY ARTHUR
Chief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-05-15+100,000→ 100,000 totalExercise: $2.75From: 2024-05-15Exp: 2033-05-15→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock option will vest in full on May 15, 2024, subject to the Reporting Person's continued service on such vesting date.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001586785
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 7:43 AM ET
- Size
- 5.5 KB